Considerations for developing a zika virus vaccine

New England Journal of Medicine

Volumn 375, Issue 13, 2016, Pages 1209-1212

  Marston, Hilary D ^a   Lurie, Nicole ^c   Borio, Luciana L ^b   Fauci, Anthony S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ZIKA VIRUS VACCINE; VIRUS VACCINE;

CLINICAL STUDY; CONGENITAL MALFORMATION; DRUG EFFICACY; DRUG SAFETY; HUMAN; IMMUNITY; IMMUNOGENICITY; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PREGNANCY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK BENEFIT ANALYSIS; VACCINATION; VACCINE PRODUCTION; VIRUS REPLICATION; ZIKA FEVER; ZIKA VIRUS; CLINICAL TRIAL (TOPIC); EPIDEMICS; FEMALE; IMMUNOLOGY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROCEDURES; ZIKA VIRUS INFECTION;

CLINICAL TRIALS AS TOPIC; EPIDEMICS; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VIRAL VACCINES; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 84990028898     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1607762     Document Type: Review

References (4)

1. Dudley DM, Aliota MT, Mohr EL, et al. A rhesus macaque model of Asian-lineage Zika virus infection. Nat Commun 2016; 7: 12204.
2. Brasil P, Pereira JP Jr, Raja Gabaglia C, et al. Zika virus infection in pregnant women in Rio de Janeiro-preliminary report. N Engl J Med. DOI: 10.1056/NEJMoa1602412.
3. Duffy MR, Chen T-H, Hancock WT, et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med 2009; 360: 2536-43.
4. Miller FG, Grady C. The ethical challenge of infection-inducing challenge experiments. Clin Infect Dis 2001; 33: 1028-33.